Stock Market Today: Glenmark Pharmaceuticals share price gained more than 5% during intraday trades on Monday post Q3 Results that were declared after the market Hours. Glenmark Pharmaceuticals on ...
The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...
Stock Market Today: Glenmark Pharmaceuticals share price gained more than 5% during intraday trades on Monday post Q3 Results that were declared after the market Hours. Glenmark Pharmaceuticals ...
Glenmark Pharmaceuticals Ltd share price was down by -0.21% from the previous closing price of ₹1,403.10. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...
Prices of key anti-diabetic drug empagliflozin crashed by as much as 90 per cent to ₹5.5 per tablet as several pharma ...
This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an expansion of Glenmark’s injectable portfolio.
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic ...
From BHEL’s new contract to Glenmark Pharma’s earnings update ... In the previous trading session, BHEL share price closed at Rs 192.93, down 4.40%. The state-run telecom company reported ...
Alivus Life Sciences Ltd share price was up by 0.64% from the previous closing price of ₹1,017.45. Who are peers of Alivus Life Sciences Ltd? The peers of Alivus Life Sciences Ltd are Sun ...
The revenue from operations at Glenmark Pharma during Q3FY25 also marked a 35.1 per cent year-on-year (YoY) rise to Rs 3,387.6 crore, coming in higher-than-estimates of Rs 3,350 crore. Glenmark Europe ...
According to Krishan, the stock is a 'buy' at the current level, with a target price of Rs 640 and a stop loss of Rs 595. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results